Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
about
Telomeres in aging and disease: lessons from zebrafishCell biology of disease: Telomeropathies: an emerging spectrum disorderSUBFOVEAL NODULE IN COATS' DISEASE: Toward an Updated Classification Predicting Visual PrognosisSuccessful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' diseaseThe effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.Indications for intravitreal bevacizumab in ibadan, sub-saharan Africa.Combined treatment for Coats' disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases.Advanced Coats' disease treated with intravitreal bevacizumab combined with laser vascular ablation.Treatment of stage 3 Coats' disease by endolaser photocoagulation via a two-port pars plana nonvitrectomy approach.Intravitreal bevacizumab injections combined with laser photocoagulation for adult-onset Coats' disease.An interesting case of Coats' diseaseCoats' Disease: Very Long-Term Outcome After Early Stage Conventional Treatment.Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.Coats' disease of adult-onset in 48 eyes.Evaluation of Follow-Up and Treatment Results in Coats' DiseaseAdverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literatureCoat's-like exudation in rhodopsin retinitis pigmentosa: successful treatment with an intravitreal dexamethasone implantSuccessful use of intravitreal ranibizumab injection and combined treatment in the management of Coats' disease.MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy.Pars plana vitrectomy for treatment of advanced Coats' disease--presentation of a modified surgical technique and long-term follow-up.Paediatric retinal detachment: a review.Coats' Disease-Related Macular Edema Treated with Combined Aflibercept and Laser Photocoagulation.The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.Rapid "epiretinal membrane" development following intravitreal bevacizumab for Coats' disease.The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats' disease.The role of intravitreal ranubizumab in the treatment of familial exudative vitreoretinopathy of stage 2 or greater.
P2860
Q26740023-817774A2-9D81-40EF-86B3-718868AAE10CQ28385689-0615E9AD-AD9A-443C-9DF0-E3E0C3E48D5FQ30490589-E582F02D-D645-4B9D-BD91-19D00D95BAECQ31137251-12AD04EC-5656-43CA-9377-EEE681BAAB08Q33716905-5D425AC9-F24E-461A-AE72-5BF023A82E0DQ34648669-6308BAC8-F11F-4DDD-B4E3-A7DADD17A4DCQ35130606-8424B874-FCBA-4C0B-8500-F70DF8CF3E19Q35176379-13011BA4-5AE8-4881-BCDC-DC5022A8063DQ35582950-8D2D696E-AD58-48C7-8778-D9744BFE2B6EQ35859489-F835BA09-B09C-4D86-B0EB-DBCC90955587Q35867987-92B4E4BD-2BA3-407F-98FA-20286C397FEDQ35970101-546D12F2-2DE1-4911-A605-824263277CE8Q36012982-1247B4AD-A3A9-44BC-9591-D3B350264FC6Q36127380-403289DF-9D34-45A5-ABFD-C73160A5C8E7Q36241655-DBFD54FD-4A0F-4BFD-8330-8588D77176DAQ38110731-F9BBC09D-F016-4F04-A4A5-2204D9A5FA06Q38709587-C96FF90C-AC57-494E-ABC5-86B49943C163Q39790799-6B69F92E-8774-4366-96F3-E3CBE6C69FE7Q41942974-4791FF20-399A-4612-B540-D813AFB54DECQ44247741-482BBCA9-1EB0-451A-BAA6-8714C8CDB6AAQ46210374-9B6D7A30-F0AC-4005-89D0-77E51D22CD9CQ47548235-7B447675-0CB9-48FD-8D73-79CBA597CBABQ47967345-87E1B0E4-6DDF-4E64-A30A-AEE673419E8EQ55389699-5BD43FAA-0D3C-4E08-AA9F-B76CDC2303FFQ55413465-CFC9D322-FF19-4CBA-A0B8-9C25B595A712Q55491252-EC9D3CB2-30D5-4DCA-BCF9-CC2CE7FF01DB
P2860
Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Bevacizumab for Coats' disease ...... isk of vitreoretinal traction.
@ast
Bevacizumab for Coats' disease ...... isk of vitreoretinal traction.
@en
type
label
Bevacizumab for Coats' disease ...... isk of vitreoretinal traction.
@ast
Bevacizumab for Coats' disease ...... isk of vitreoretinal traction.
@en
prefLabel
Bevacizumab for Coats' disease ...... isk of vitreoretinal traction.
@ast
Bevacizumab for Coats' disease ...... isk of vitreoretinal traction.
@en
P1476
Bevacizumab for Coats' disease ...... isk of vitreoretinal traction.
@en
P2093
Aparna Ramasubramanian
Carol L Shields
P304
P356
10.1136/BJOPHTHALMOL-2011-300141
P407
P577
2011-06-07T00:00:00Z